Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Izzy who wrote (4930)	7/21/1998 5:13:00 PM
From: sam	Read Replies (1) of 6136

My guess is there will be another stock traded under a separate symbol. It appears -- on first blush -- that AGPH wants to create value in its cancer program. It believes the street values it SOLELY on it's AIDS program (i.e. Viracept). By "spinning off" its cancer program it forces the street to place at least SOME value on the purely "biotech" cancer program (even if its only a couple of dollars). The new stock will move on news that wasn't able to budge AGPH (now firmly seeking AMGN-like status) in the past. Just a guess based on this quote from Peter Johnson: "we seek to unlock what we believe to be the largely unappreciated value of our R&D pipeline of products for oncology and related fields."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next